PIK3CA

You have access
Biomarkers of cetuximab resistance in patients with head and neck squamous cell carcinoma
Olivia Leblanc, Sophie Vacher, Charlotte Lecerf, Emmanuelle Jeannot, Jerzy Klijanienko, Frédérique Berger, Caroline Hoffmann, Valentin Calugaru, Nathalie Badois, Anne Chilles, Maria Lesnik, Samar Krhili, Ivan Bieche, Christophe Le Tourneau and Maud Kamal

Cancer Biology & Medicine February 2020, 17 (1) 208-217; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0153
You have access
Effects of palbociclib on oral squamous cell carcinoma and the role of PIK3CA in conferring resistance
Nur Syafinaz Zainal, Bernard Kok Bang Lee, Zheng Wei Wong, Iuan Sheau Chin, Pei San Yee, Chai Phei Gan, Kein Seong Mun, Zainal Ariff Abdul Rahman, J. Silvio Gutkind, Vyomesh Patel and Sok Ching Cheong

Cancer Biology & Medicine May 2019, 16 (2) 264-275; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0257
You have access
Predictive value of K-ras and PIK3CA in non-small cell lung cancer patients treated with EGFR-TKIs: a systemic review and meta-analysis
Jie-Ying Chen, Ya-Nan Cheng, Lei Han, Feng Wei, Wen-Wen Yu, Xin-Wei Zhang, Shui Cao and Jin-Pu Yu

Cancer Biology & Medicine June 2015, 12 (2) 126-139; DOI: https://doi.org/10.7497/j.issn.2095-3941.2015.0021

Main menu